Glulisine insulin is the latest addition to the class of rapid-acting insulin analogues. It is important that it is comparable in safety not only to human regular insulin, but also to the well established analogue insulins, aspart and lispro. In this summary the evidence comparing the safety ...
To reduce postprandial glycemic excursions in patients, ultra-rapid-insulin formulations in a combination of novel excipients with hexamer insulins have been developed by various companies and brought to the market, such as insulin apart with nicotinamide (Novo Nordisk) and insulin lispro with citrate...
Brunelle BL, Llewelyn J, Anderson Jr JH, et al. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 1998 Oct; 21(10): 1726–31 ArticlePubMedCASGoogle Scholar Garcia L, Lamas C, Tuset MJ, et al. Treatment with the insuli...
Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087. SH) announced that Gan & Lee's self-developed Class 1.1 new drug GZR101 has initiated Phase I clinical trials and the first subject has been dosed. GZR101 is a premixed dual insulin co-formulation composed of ultra-long-...
AWARD 4 was a random, open level phase 3 trial, 52 week study conducted with Dulaglutide versus bed time insulin glargine both in combination with prandial insulin lispro in T2DM patients. The study for a time period of 52 weeks resulted in significant decrease in HbA1c, weight reduction and...
Examples of DDIs in DrugBank only include acebutolol/Insulin Lispro and metronidazole/terfenadine. Examples of DDIs in NDF-RT only include amiodarone/sotalol and meperidine/linezolid. When we only consider DDIs from the reference set, the overlap between DrugBank and NDF-RT is significantly ...
(human) inj 500 unit/ml NOVOLIN R - insulin regular (human) inj 1 100 unit/ml NOVOLIN R RELION - insulin regular (human) inj 100 unit/ml 1 RELION R - insulin regular (human) inj 2 100 unit/ml Intermediate-Acting Insulins HUMALOG MIX 50/50 - insulin lispro prot & lispro (human) ...
Insulin Degludec TresibaUltra long acting Insulin Lispro HumalogRapid-Acting Insulin Insulin Aspart NovologRapid-Acting Insulin Humulin and Novolin 70/30 70% NPH and 30% Regular Which insulins are considered to be rapid-acting? NovoLog, Apidra, and Humalog Which insulins are considered to be shor...
About Gan & Lee Gan & Lee successfully developed the first Chinese domestic biosynthetic human insulin. At present, the company has five recombinant insulin analogs commercialized in China including long-acting glargine injection (Basalin®), fast-acting lispro injection (Prandilin®), mixed prota...
Gan & Lee successfully developed the first Chinese domestic biosynthetic human insulin. The company has five recombinant insulin analogs commercialized in China including long-acting glargine injection (Basalin(R)), fast-acting lispro injection (Prandilin(R)), fast-acting aspart injection (Rapilin(TM...